Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centrexion Therapeutics
Age
18–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Is in good general health as determined by the Investigator's review
Has a body mass index (BMI) between 18 and 35kg/m\^2, inclusive
For females, is not currently pregnant or breastfeeding and is either of non-childbearing potential or willing to use an adequate method of birth control
For males, must agree to use barrier contraception and not to donate sperm
You may not be if
Has a history of cardiac disease, including congestive heart failure, angina, or any arrhythmia
Has diabetes mellitus, acromegaly, clinically active thyroid disease, or other active endocrinopathy
Has any history or currently active type of cancer except excised or cured basal cell carcinoma
Has a gastrointestinal disorder that could interfere with the absorption of orally administered drugs
Has asthma or other severe respiratory disease (e.g., chronic obstructive pulmonary disease) requiring daily prescription medicine
Currently has kidney, neurologic, metabolic, or liver disease, or other organ system disease
Has a history, current evidence, or is being treated for depression, suicidal ideation, suicide attempt, or any other current psychiatric condition requiring active treatment
Has an immunological disorder such as, but not limited to, human immunodeficiency virus (HIV), acquired, or congenital immune deficiency syndrome; autoimmune diseases, such as, but not limited to, rheumatoid arthritis, systemic lupus erythematosus, seronegative spondyloarthropathies or vasculitis, or any infection
Has positive screening test for hepatitis B virus (HBV) or hepatitis C virus (HCV);
Is pregnant, lactating, or planning a pregnancy during the study
Has used any prescribed medication within 30 days prior to the first admission or has plans to use any prescribed medication during the study (with the exception of hormonal contraceptives)
Has used within 14 days prior to the first admission or has plans to use during the study any over-the-counter medicinal products, including herbal and dietary supplements (except for occasional use of acetaminophen or NSAIDs, such as ibuprofen or naproxen; calcium; or Vitamin D)
Use of any of the following:
* Human growth hormone, octreotide, anti-diabetic medication, or thyroid suppressors or supplements
* Immunosuppressive drugs within 30 days of study start, or 5 half-lives of the drug (whichever is longer), or plans to use during the study
Clareo Health | A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects
